ID: h-gap-2f2e5b80-m1
Hypothesis

TLR4 priming is the actionable driver in: How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration th

The gap can be tested by treating TLR4 priming as an upstream driver rather than a passive correlate.
🧬 TLR4 priming🩺 neurodegeneration🎯 Composite 34%💱 $0.53▼21.9%active
EvidencePending (0%)📖 6 cit🗣 2 debates 6 support 1 oppose
✓ All Quality Gates Passed
🏆 ChallengeValidate TLR4 priming as actionable driver in gut-brain neurodegeneration axis$450 →

🧪 Overview

The gap can be tested by treating TLR4 priming as an upstream driver rather than a passive correlate. If true, perturbing butyrate-restoring consortia should shift fecal butyrate before downstream neurodegeneration markers change.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Gut Dysbiosis<br/>SCFA-Producing Bacteria Loss"]
    B["Intestinal Permeability<br/>Leaky Gut Endotoxemia"]
    C["LPS Translocation<br/>Portal and Systemic Circulation"]
    D["TLR4 Activation<br/>MD-2 Coreceptor Complex"]
    E["MyD88 Signaling<br/>NF-kappaB and MAPK Cascade"]
    F["Peripheral Cytokine Storm<br/>IL-1beta and TNF Secretion"]
    G["Microglial Priming<br/>Brain Resident Immune Activation"]
    H["Neurodegeneration<br/>Synapse Loss and Tau Pathology"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    G --> H
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style D fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports1 contradicts
Supports
TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling.
Cell Mol Life Sci2021PMID:33057840medium
Supports
The role of the microbiota in glaucoma.
Mol Aspects Med2023PMID:37866106medium
Supports
The role of Toll-like receptors and neuroinflammation in Parkinson's disease.
J Neuroinflammation2022PMID:35668422medium
Supports
Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and microglial activation in an AD model.
Phytomedicine2024PMID:38552431medium
Supports
α-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease.
Aging Cell2021PMID:34811872medium
Contradicts
causal direction requires longitudinal perturbation
skeptic_round
📖 Linked Papers (15)Export BibTeX ↗
No figures
No figures
No figures
The role of the microbiota in glaucoma.
Molecular aspects of medicine (2023) · PubMed:37866106 ↗
No figures
The role of the microbiota in glaucoma.
Molecular aspects of medicine (2023) · PubMed:37866106 ↗
No figures

🏥 Translation

🧬 3D Protein Structure — TLR4

🧬 PDB 3FXI Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for TLR4 priming from GTEx v10.

Caudate basal ganglia4.7 Nucleus accumbens basal ganglia4.2 Substantia nigra4.2 Amygdala4.2 Putamen basal ganglia3.9 Cortex3.6median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for TLR4 priming →

No DepMap CRISPR Chronos data found for TLR4 priming.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.6%
Volatility
High
0.1444
Events (7d)
3
Price History
▼21.9%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF TLR4 priming is the gut-dysbiosis driver of neuroinflammation, THEN fecal microbiota transfer from dysbiotic donors will raise microglial TLR4/NF-kB activation by >=30% within 6 weeks in germ-free Recipient mice show >=30% increase in microglial TLR4/NF-kB activation markers versus healthy-donor FMT recipients.— no observation —pending0.65
IF TLR4 is actionable upstream, THEN pharmacologic or genetic TLR4 inhibition will prevent at least 50% of dysbiosis-induced IL-1B/TNF microglial upregulation within 8 weeks.TLR4 inhibition reduces dysbiosis-induced microglial IL-1B/TNF signal by >=50% versus untreated dysbiotic controls.— no observation —pending0.62
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF TLR4 priming is the gut-dysbiosis driver of neuroinflammation, THEN fecal microbiota transfer from dysbiotic donors will raise microglial TLR4/NF-kB activation by >=30% within 6 weeks in germ-free mice.
Predicted outcome: Recipient mice show >=30% increase in microglial TLR4/NF-kB activation markers versus healthy-donor FMT recipients.
Falsification: Activation increase is <10% or is unchanged by TLR4 blockade.
pendingconf 62%
IF TLR4 is actionable upstream, THEN pharmacologic or genetic TLR4 inhibition will prevent at least 50% of dysbiosis-induced IL-1B/TNF microglial upregulation within 8 weeks.
Predicted outcome: TLR4 inhibition reduces dysbiosis-induced microglial IL-1B/TNF signal by >=50% versus untreated dysbiotic controls.
Falsification: TLR4 inhibition reduces cytokine signal by <20% despite target engagement.
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
sourcev1_phase_c_backfill
origin_typedebate_synthesis
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.